Loading...
Last submissions
-
-
-
-
Raquel Dávila Fajardo, Rhoikos Furtwängler, Martine van Grotel, Harm van Tinteren, Claudia Pasqualini, et al.. Outcome of Stage IV Completely Necrotic Wilms Tumour and Local Stage III Treated According to the SIOP 2001 Protocol. Cancers, 2021, 13 (5), pp.976. ⟨10.3390/cancers13050976⟩. ⟨hal-03520022⟩
-
-
Stéphane Culine, Aude Fléchon, Gwenaelle Gravis, Guilhem Roubaud, Yohann Loriot, et al.. Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With or Without Panitumumab in Patients With Advanced Urothelial Carcinoma: Multicenter, Randomized, French Unicancer GETUG/AFU 19 Study. Clinical Genitourinary Cancer, 2021, 19 (4), pp.e216-e222. ⟨10.1016/j.clgc.2021.02.005⟩. ⟨hal-03631553⟩
-
Yé Fan, Cédric Pionneau, Federico Cocozza, Pierre‐yves Boëlle, Solenne Chardonnet, et al.. Differential proteomics argues against a general role for CD9, CD81 or CD63 in the sorting of proteins into extracellular vesicles. Journal of Extracellular Vesicles, 2023, 12 (8), ⟨10.1002/jev2.12352⟩. ⟨hal-04178027⟩
-
P. Pautier, A. Floquet, C. Chevreau, N. Penel, C. Guillemet, et al.. A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgery. ESMO Open, 2021, 6 (4), pp.100209. ⟨10.1016/j.esmoop.2021.100209⟩. ⟨hal-03623631⟩
-
D. Dano, A. Lardy-Cleaud, A. Monneur, N. Quenel-Tueux, C. Levy, et al.. Metastatic inflammatory breast cancer: survival outcomes and prognostic factors in the national, multicentric, and real-life French cohort (ESME). ESMO Open, 2021, 6 (4), pp.100220. ⟨10.1016/j.esmoop.2021.100220⟩. ⟨hal-03426433⟩
-
Florian Roisné-Hamelin, Sabrina Pobiega, Kévin Jézéquel, Simona Miron, Jordane Dépagne, et al.. Avelumab Versus Docetaxel in Patients With Platinum-Treated Advanced NSCLC: 2-Year Follow-Up From the JAVELIN Lung 200 Phase 3 Trial. Journal of Thoracic Oncology, 2021, 16 (8), pp.1369-1378. ⟨10.1016/j.jtho.2021.03.009⟩. ⟨hal-03627353⟩
-
Jonathan Khalifa, Stéphane Supiot, Géraldine Pignot, Christophe Hennequin, Pierre Blanchard, et al.. Recommendations for planning and delivery of radical radiotherapy for localized urothelial carcinoma of the bladder. Radiotherapy & Oncology, 2021, 161, pp.95-114. ⟨10.1016/j.radonc.2021.06.011⟩. ⟨hal-03612787⟩
-
Pauline Marolleau, David Tougeron, Benoît ALLIGNET, Romain Cohen, David Sefrioui, et al.. Complete pathological response after chemotherapy or immune checkpoint inhibitors in deficient MMR metastatic colorectal cancer: Results of a retrospective multicenter study. International Journal of Cancer, In press, ⟨10.1002/ijc.34636⟩. ⟨hal-04155601⟩
-
Renaud Sabatier, Jean-Yves Pierga, Hervé Curé, Rakan Abulnaja, Eric Lambaudie, et al.. Circulating Tumor Cells and Bevacizumab Pharmacokinetics during Neoadjuvant Treatment Combining Chemotherapy and Bevacizumab for Early Breast Cancer: Ancillary Analysis of the AVASTEM Trial. Cancers, 2021, 13 (1), pp.140. ⟨10.3390/cancers13010140⟩. ⟨hal-03622751⟩
-
-
Sébastien Gendarme, Sonia Zebachi, Romain Corre, Laurent Greillier, Grégoire Justeau, et al.. Predictors of three-month mortality and severe chemotherapy-related adverse events in patients aged 70 years and older with metastatic nonsmall-cell lung cancer: a secondary analysis of ESOGIA-GFPC-GECP 08-02 Study. Journal of Geriatric Oncology, 2023, pp.101506. ⟨10.1016/j.jgo.2023.101506⟩. ⟨hal-04150041⟩
-
Clémence Romeo, Olivia Le Saux, Margaux Jacobs, Florence Joly, Gwenael Ferron, et al.. Therapeutic Challenges in Patients with Gynecologic Carcinosarcomas: Analysis of a Multicenter National Cohort Study from the French Prospective TMRG Network. Cancers, 2022, 14 (2), pp.354. ⟨10.3390/cancers14020354⟩. ⟨hal-03622814⟩
-
Maud Maillard, Manon Launay, Bernard Royer, Jérome Guitton, Elodie Gautier-Veyret, et al.. Quantitative impact of pre-analytical process on plasma uracil when testing for dihydropyrimidine dehydrogenase deficiency. British Journal of Clinical Pharmacology, 2022, Global Pharmacovigilance, 89 (5), pp.762-772. ⟨10.1111/bcp.15536⟩. ⟨hal-03789849⟩
-
Renaud Sabatier, Cécile Vicier, Séverine Garnier, Arnaud Guille, Nadine Carbuccia, et al.. Circulating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: plasma analysis of the TAKTIC phase IB/II study. Molecular Oncology, 2022, 16 (10), pp.2057-2070. ⟨10.1002/1878-0261.13188⟩. ⟨hal-03583253⟩
-
-
Roman Rouzier, Paolo Pronzato, Élisabeth Chéreau, Josh John Carlson, Barnaby Hunt, et al.. Multigene assays and molecular markers in breast cancer: Systematic review of health economic analyses. Breast Cancer Research and Treatment, 2013, 139 (3), pp.621-637. ⟨10.1007/s10549-013-2559-1⟩. ⟨hal-02573790⟩